eTPD: A New Era in Drug DiscoveryeTPDExtracellular Targeted Protein Degradation (eTPD) is a revolutionary approach in drug discovery, targeting extracellular and membrane proteins for therapeutic purposes, offering unique advantages over traditional biologics and small molecules.
Humanity's Lifespan EvolutionPenicillin
Aspirin
ArtemisininExplore the evolution of human lifespan, historical epidemics, life-saving medicines, and why women tend to live longer—all highlighting humanity's relentless pursuit of extending life.
Just Five Drops of Blood Can Reveal Your True Biological AgeSteroidA new AI model developed by Osaka University accurately predicts biological age using just five drops of blood, analyzing steroid metabolism. It unveils new insights into aging, including the impacts of cortisol and smoking.
Revolutionary Development in Cancer Immunotherapy: Pep-TACsCancerPep-TACs, a new breakthrough in cancer immunotherapy, offer a novel platform for targeted protein degradation. Unlike traditional technologies, Pep-TACs overcome challenges like drug resistance, tumor penetration, and blood-brain barrier limitations.
Drug RA | FDA: December 2024 Training: Innovative Therapies - Gene TherapyFDAThe FDA's December 2024 Clinical Investigator Training Course focused on gene therapy, covering key stages in the development of cell and gene therapies. The session also introduced new initiatives to support rare disease treatments and improve regulatory processes.
